Company Profile
Axomove is a France-based manufacturer of digital medical devices for musculoskeletal prevention and rehabilitation, headquartered in Lille, France. Founded in 2017 by Boris Lévêque, Pierre-Yves Carlier, Alexandre Morel, and Clément Morel, the company commercially launched its platform in 2019. The privately held company employs 30 people and serves 150 B2B clients and 75,000 users across hospitals, insurers, and employers in France.
Core Products ＆ Technologies
Axomove Therapy Digital Platform
• Digital Medical Device (MD): CE-marked software platform delivering personalized rehabilitation and prevention programs
• Video Exercise Library: Over 1,500 therapeutic exercise programs designed by physiotherapists for conditions including lower back pain, tendonitis, and carpal tunnel syndrome
• Telerehabilitation Module: Remote physiotherapy sessions with real-time professional guidance and video teleconsultation
• Educational Content: Pathology sheets, quizzes, and 3D videos to raise patient awareness and engagement
Care Pathway Integration
• Digital Clinic for Employers: Workplace musculoskeletal prevention programs targeting TMS disorders, which account for approximately 30% of sick leave in France
• Hospital Discharge Support: Post-acute care continuity for rehabilitation centers and university hospitals including CHU de Lille and Ramsay Santé
• Insurer Integration: Embedded within provident contracts for population-level MSK risk management; partners include Allianz, Alliance Klesia-Generali, and APRIL International
Planned Platform Enhancements
• Advanced Motion Capture: Biomechanical analysis and posture correction through device camera integration (development funded by 2026 Series A)
• Gamification Features: Interactive challenges and progress rewards to improve long-term treatment adherence (roadmap 2026–2027)
Market Position ＆ Certifications
Axomove holds a leading position in the French digital rehabilitation segment, competing with SWORD Health, Hinge Health, Kaia Health, and MindMaze. Key strengths include:
• Reimbursement leadership: Currently the only solution in its category reimbursed by French National Health Insurance (PECAN pathway) for chronic lower back pain
• Evidence-based design: All content developed using evidence-based practice methodology in collaboration with healthcare professionals and university hospitals
• Regulatory compliance: CE marked as a medical device, GDPR compliant
• Clinical outcomes: Company-reported data shows doubled functional capacity, 5x treatment adherence, 50% reduction in absenteeism, and 3x lower healthcare expenses
Corporate Timeline
2017 — Founded in Lille by Boris Lévêque, Pierre-Yves Carlier, Alexandre Morel, and Clément Morel
2019 — Commercial launch of Axomove Therapy platform; first hospital client (Espoir centre, Lille)
2022 — Raised €1.6 million led by Faraday Venture Partners with Santélys and Groupe JLO; obtained PECAN reimbursement from French National Health Insurance
2025 — Partnership with Allianz France for group benefits contracts; APRIL International integration for expatriate telephysiotherapy
2026 — Closed €4 million Series A co-led by Bpifrance Digital Prevention Fund and Go Capital, with Inco Ventures and Faraday Venture Partners; plans to double workforce within three years and expand reimbursement to metabolic diseases including obesity
Target Markets ＆ Applications
• Chronic Lower Back Pain: Reimbursed digital rehabilitation and prevention pathways
• Post-Surgical Orthopedic Recovery: Hip, knee, and shoulder replacement rehabilitation
• Neurological Rehabilitation: Post-stroke motor recovery and functional maintenance
• Workplace MSK Prevention: Corporate digital clinics for ergonomic risk and musculoskeletal disorder prevention
• Metabolic Conditions: Planned expansion into obesity and related musculoskeletal comorbidities via ON-TRAC clinical study
Contact Information
Global Headquarters
Address: 117 Allée Clementine Deman, 59000 Lille, France
Website: www.axomove.com
